PRODROMAL SCHIZOPHRENIA
Clinical trials for PRODROMAL SCHIZOPHRENIA explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL SCHIZOPHRENIA trials appear
Sign up with your email to follow new studies for PRODROMAL SCHIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can family talks prevent psychosis? new trial tests therapy for at-risk youth
Disease control OngoingThis study tests a family-focused therapy for 220 youth aged 13-25 who show early signs of psychosis risk. The therapy involves family sessions to reduce symptoms and prevent the condition from getting worse. Participants are followed for 18 months to see if the therapy helps low…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Can quick brain zaps tame psychosis?
Symptom relief TerminatedThis study tests whether an accelerated schedule of transcranial magnetic stimulation (TMS) is safe and tolerable for people with psychotic disorders like schizophrenia. Twenty adults aged 18-65 will receive the treatment and be monitored for side effects. The goal is to see if t…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Apr 26, 2026 19:39 UTC
-
Can early, Step-Based care prevent psychosis in At-Risk youth?
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a specialized program for people aged 12-25 who show early signs that may lead to psychosis. The program uses a step-based approach to provide care tailored to each person's needs. Researchers will track participants for up to 24 months to see if symptoms an…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated May 17, 2026 12:53 UTC